Ferraz, A.M.L.; Bandarra, S.; Mascarenhas, P.; Barahona, I.; Martins, R.; Ribeiro, A.C.
Characterization of CYP2C19*17 Polymorphism in a Portuguese Population Sample Relevant for Proton Pump Inhibitor Therapy—A Pilot Study. Med. Sci. Forum 2021, 5, 19.
https://doi.org/10.3390/msf2021005019
AMA Style
Ferraz AML, Bandarra S, Mascarenhas P, Barahona I, Martins R, Ribeiro AC.
Characterization of CYP2C19*17 Polymorphism in a Portuguese Population Sample Relevant for Proton Pump Inhibitor Therapy—A Pilot Study. Medical Sciences Forum. 2021; 5(1):19.
https://doi.org/10.3390/msf2021005019
Chicago/Turabian Style
Ferraz, Adriana M. L., Susana Bandarra, Paulo Mascarenhas, Isabel Barahona, Rui Martins, and Ana Clara Ribeiro.
2021. "Characterization of CYP2C19*17 Polymorphism in a Portuguese Population Sample Relevant for Proton Pump Inhibitor Therapy—A Pilot Study" Medical Sciences Forum 5, no. 1: 19.
https://doi.org/10.3390/msf2021005019
APA Style
Ferraz, A. M. L., Bandarra, S., Mascarenhas, P., Barahona, I., Martins, R., & Ribeiro, A. C.
(2021). Characterization of CYP2C19*17 Polymorphism in a Portuguese Population Sample Relevant for Proton Pump Inhibitor Therapy—A Pilot Study. Medical Sciences Forum, 5(1), 19.
https://doi.org/10.3390/msf2021005019